The Ascent of Precision Medicines
Traditionally the pharma industry has lent towards the view of a one-size fits all approach to the application of therapeutics. Now, eyes are set firmly on the notion of personalised medicine – therapeutics which are tailored to a patient’s specific biomarker information. The progression of next generation sequencing and genome technology is allowing for the first tangible personalised therapies to emerge.However, there are still major strides to be made within molecular diagnostics and the sequ...
To continue reading this story get free access
Please note: That all fields marked with an asterisk (*) are required.